Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Pharmacogenomics of hypertension: a genome-wide, placebo-controlled cross-over study, using four classes of antihypertensive drugs.
To tell or not to tell: attitudes of transplant surgeons and transplant nephrologists regarding the disclosure of recipient information to living kidney donors.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacogenomics of hypertension: a genome-wide, placebo-controlled cross-over study, using four classes of antihypertensive drugs.
Pharmacogenomics of hypertension: a genome-wide, placebo-controlled cross-over study, using four classes of antihypertensive drugs. J Am Heart Assoc. 2015 Jan 26; 4(1):e001521.
View in:
PubMed
subject areas
Adult
Aldehyde Oxidoreductases
Amlodipine
Antihypertensive Agents
Benzimidazoles
Biphenyl Compounds
Bisoprolol
Blood Pressure Monitoring, Ambulatory
Chloride Channels
Cross-Over Studies
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Essential Hypertension
Finland
Genome-Wide Association Study
Humans
Hydrochlorothiazide
Hypertension
Losartan
Male
Membrane Proteins
Meta-Analysis as Topic
Microfilament Proteins
Middle Aged
Mutation, Missense
Pharmacogenetics
Polymorphism, Single Nucleotide
Severity of Illness Index
Tetrazoles
Treatment Outcome
authors with profiles
Arlene Chapman